These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1659309)

  • 81. Temporal prevalence of antimicrobial resistance in Campylobacter spp. from beef cattle in Alberta feedlots.
    Inglis GD; Morck DW; McAllister TA; Entz T; Olson ME; Yanke LJ; Read RR
    Appl Environ Microbiol; 2006 Jun; 72(6):4088-95. PubMed ID: 16751519
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Emergence of Fluoroquinolone-Resistant
    Abraham S; Sahibzada S; Hewson K; Laird T; Abraham R; Pavic A; Truswell A; Lee T; O'Dea M; Jordan D
    Appl Environ Microbiol; 2020 Apr; 86(8):. PubMed ID: 32033955
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lack of Evidence for erm(B) Infiltration Into Erythromycin-Resistant Campylobacter coli and Campylobacter jejuni from Commercial Turkey Production in Eastern North Carolina: A Major Turkey-Growing Region in the United States.
    Bolinger HK; Zhang Q; Miller WG; Kathariou S
    Foodborne Pathog Dis; 2018 Nov; 15(11):698-700. PubMed ID: 30096008
    [TBL] [Abstract][Full Text] [Related]  

  • 84. In vitro susceptibility to antimicrobial agents and ultrastructural characteristics related to swimming motility and drug action in Campylobacter jejuni and C. coli.
    Yabe S; Higuchi W; Takano T; Razvina O; Iwao Y; Isobe H; Yamamoto T
    J Infect Chemother; 2010 Jun; 16(3):174-85. PubMed ID: 20225076
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Trend analysis of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli isolated from Belgian pork and poultry meat products using surveillance data of 2004-2009.
    Mattheus W; Botteldoorn N; Heylen K; Pochet B; Dierick K
    Foodborne Pathog Dis; 2012 May; 9(5):465-72. PubMed ID: 22510058
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Characterization of erythromycin resistance in Campylobacter coli and Campylobacter jejuni isolated from pig offal in New Zealand.
    Harrow SA; Gilpin BJ; Klena JD
    J Appl Microbiol; 2004; 97(1):141-8. PubMed ID: 15186451
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.
    Engberg J; Neimann J; Nielsen EM; Aerestrup FM; Fussing V
    Emerg Infect Dis; 2004 Jun; 10(6):1056-63. PubMed ID: 15207057
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.
    Hirschl AM; Wolf D; Berger J; Rotter ML
    Zentralbl Bakteriol; 1990 Apr; 272(4):443-7. PubMed ID: 2360966
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Resistance to quinolones among Campylobacter species--Ontario.
    Preston MA; Brown S; Borczyk A
    Can Commun Dis Rep; 1995 Sep; 21(17):156-60. PubMed ID: 7581214
    [No Abstract]   [Full Text] [Related]  

  • 90. Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.
    Gomez-Garces JL; Cogollos R; Alos JL
    Antimicrob Agents Chemother; 1995 Feb; 39(2):542-44. PubMed ID: 7726529
    [TBL] [Abstract][Full Text] [Related]  

  • 91. In vitro activity of azithromycin against bacterial enteric pathogens.
    Gordillo ME; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1993 May; 37(5):1203-5. PubMed ID: 8390813
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro activity of azithromycin against clinical isolates of Legionella species.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1991 Jan; 35(1):180-1. PubMed ID: 1849708
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Differential effects of temperature on natural transformation to erythromycin and nalidixic acid resistance in Campylobacter coli.
    Kim JS; Kim JW; Kathariou S
    Appl Environ Microbiol; 2008 Oct; 74(19):6121-5. PubMed ID: 18708520
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Susceptibility of Shigella species to erythromycin.
    Greenberg RN; Pearson RD; Innes DJ; Sauer KT; Halterman LD; Guerrant RL
    Antimicrob Agents Chemother; 1982 Feb; 21(2):347-8. PubMed ID: 7073270
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria.
    Kitzis MD; Goldstein FW; Miégi M; Acar JF
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():15-8. PubMed ID: 2154432
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.
    Pajukanta R; Asikainen S; Saarela M; Alaluusua S; Jousimies-Somer H
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1241-3. PubMed ID: 1329617
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole.
    Ravdin JI; Skilogiannis J
    Antimicrob Agents Chemother; 1989 Jun; 33(6):960-2. PubMed ID: 2548442
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cloning and expression of the erythromycin resistance determinant from Campylobacter jejuni in Escherichia coli.
    Son R; Ansary A
    World J Microbiol Biotechnol; 1995 Nov; 11(6):685-6. PubMed ID: 24415023
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives.
    Kibwage IO; Hoogmartens J; Roets E; Vanderhaeghe H; Verbist L; Dubost M; Pascal C; Petitjean P; Levol G
    Antimicrob Agents Chemother; 1985 Nov; 28(5):630-3. PubMed ID: 4091529
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular Basis of Macrolide Resistance in
    Wei B; Kang M
    Biomed Res Int; 2018; 2018():4526576. PubMed ID: 30069469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.